| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,926 |
11,443 |
$1.22M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,087 |
5,417 |
$517K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,082 |
4,903 |
$465K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,138 |
4,732 |
$333K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,125 |
3,029 |
$285K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
11,710 |
11,084 |
$213K |
| H0025 |
Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) |
1,407 |
1,219 |
$191K |
| 92587 |
|
5,388 |
5,247 |
$186K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,465 |
1,406 |
$146K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
6,818 |
6,493 |
$124K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,149 |
3,021 |
$116K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,748 |
3,434 |
$76K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
4,982 |
4,478 |
$52K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,043 |
2,857 |
$48K |
| 99215 |
Prolong outpt/office vis |
354 |
317 |
$46K |
| 99381 |
|
447 |
427 |
$42K |
| 96127 |
|
2,142 |
1,922 |
$34K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
766 |
708 |
$32K |
| 99173 |
|
3,992 |
3,858 |
$29K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
992 |
872 |
$29K |
| 90474 |
|
2,427 |
2,353 |
$26K |
| H0023 |
Behavioral health outreach service (planned approach to reach a targeted population) |
149 |
134 |
$22K |
| 36406 |
|
1,847 |
1,739 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
852 |
583 |
$16K |
| 90651 |
|
645 |
603 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
969 |
878 |
$14K |
| 90670 |
|
2,339 |
2,186 |
$14K |
| D0145 |
Oral evaluation for a patient under three years of age |
327 |
324 |
$10K |
| 90734 |
|
449 |
396 |
$8K |
| 90480 |
|
155 |
145 |
$6K |
| D1206 |
Topical application of fluoride varnish |
387 |
384 |
$6K |
| 90698 |
|
2,201 |
2,068 |
$6K |
| 90710 |
|
498 |
478 |
$5K |
| 0071A |
|
100 |
92 |
$5K |
| 99382 |
|
46 |
43 |
$4K |
| 85018 |
|
1,712 |
1,650 |
$4K |
| 90680 |
|
1,892 |
1,773 |
$4K |
| 94760 |
|
2,089 |
1,877 |
$3K |
| 0072A |
|
52 |
51 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
161 |
135 |
$3K |
| 90633 |
|
1,468 |
1,403 |
$3K |
| 99383 |
|
27 |
24 |
$3K |
| 90716 |
|
571 |
545 |
$3K |
| 90677 |
|
433 |
429 |
$3K |
| 99000 |
|
1,871 |
1,739 |
$2K |
| 90688 |
|
1,982 |
1,819 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
17 |
12 |
$2K |
| 99384 |
|
14 |
12 |
$2K |
| 90715 |
|
285 |
255 |
$2K |
| 90707 |
|
542 |
517 |
$1K |
| 90696 |
|
434 |
420 |
$1K |
| 90744 |
|
1,491 |
1,417 |
$1K |
| 0081A |
|
16 |
12 |
$741.24 |
| 0001A |
|
16 |
12 |
$729.47 |
| 99460 |
|
13 |
12 |
$681.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
31 |
29 |
$540.60 |
| 36410 |
|
66 |
63 |
$538.59 |
| 99441 |
|
34 |
33 |
$500.82 |
| 90687 |
|
1,043 |
970 |
$462.96 |
| 94010 |
|
15 |
15 |
$462.15 |
| 90700 |
|
320 |
301 |
$428.30 |
| 90658 |
|
101 |
94 |
$337.65 |
| 96380 |
|
14 |
14 |
$296.38 |
| 94664 |
|
49 |
38 |
$243.55 |
| 99070 |
|
19 |
17 |
$160.68 |
| 91319 |
|
37 |
35 |
$136.40 |
| 81002 |
|
98 |
96 |
$124.51 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
77 |
57 |
$69.02 |
| A7015 |
Aerosol mask, used with dme nebulizer |
62 |
46 |
$60.34 |
| 91318 |
|
22 |
21 |
$40.00 |
| 96161 |
|
1,356 |
1,181 |
$31.59 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
128 |
123 |
$26.56 |
| 90656 |
|
322 |
320 |
$23.53 |
| 87280 |
|
107 |
82 |
$22.81 |
| 90648 |
|
234 |
218 |
$15.35 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
118 |
95 |
$0.36 |
| 99051 |
|
43 |
41 |
$0.00 |
| 91300 |
|
81 |
71 |
$0.00 |
| 99188 |
|
332 |
328 |
$0.00 |
| 91308 |
|
24 |
19 |
$0.00 |
| 91320 |
|
14 |
14 |
$0.00 |
| 98960 |
|
19 |
19 |
$0.00 |
| 91307 |
|
172 |
161 |
$0.00 |
| 90381 |
|
13 |
13 |
$0.00 |